Drug Profile
RG 7775
Alternative Names: RG7775; RO 6839921Latest Information Update: 28 Apr 2021
Price :
$50
*
At a glance
- Originator Roche
- Class Antineoplastics; Small molecules
- Mechanism of Action Proto-oncogene protein c mdm2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Acute myeloid leukaemia; Solid tumours
Most Recent Events
- 28 Apr 2021 No recent reports of development identified for phase-I development in Acute-myeloid-leukaemia(Second-line therapy or greater) in Canada (IV, Infusion)
- 28 May 2020 No recent reports of development identified for phase-I development in Acute-myeloid-leukaemia(Second-line therapy or greater) in USA (IV, Infusion)
- 28 May 2020 No recent reports of development identified for phase-I development in Solid-tumours(Late-stage disease) in Canada (IV, Infusion)